March 21, 2024 3:05 PM CET

HRD testing in ovarian cancer samples using comprehensive genomic profiling

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

HRD Testing in Ovarian Cancer Samples Using Comprehensive Genomic Profiling 

Dr. Normanno will present the experience of his laboratory evaluating the Ion Torrent Oncomine Comprehensive Assay Plus*, a targeted NGS approach that can help clinical research in identifying all relevant biomarkers now including also HRD.